6568 · KNC Laboratories Co., Ltd. · Financials
Market Cap
9.20B JPY
Shares
7.74M
Volume · Nov 12
6000
Avg daily vol (3M)
3911
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
9.09B
+11.2%
FY2026
Net Income
766.2M
+3.9%
FY2026
Gross Margin
26.26%
-2.1pp
FY2026
Operating Margin
11.27%
+1.8pp
FY2026
Operating Cash Flow
2.26B
+52.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 9.09B | 8.18B | 9.15B | 8.63B | 7.44B |
| JPY | 6.71B | 5.86B | 5.86B | 5.32B | 5.33B |
| JPY | 2.39B | 2.32B | 3.3B | 3.3B | 2.11B |
| JPY | 1.02B | 771.86M | 2.08B | 2.16B | 1.09B |
| JPY | 1.03B | 927.99M | 2.09B | 2.17B | 916.77M |
| JPY | 259.63M | 190.66M | 600.16M | 629.52M | 273.3M |
| JPY | 766.2M | 737.33M | 1.49B | 1.54B | 643.46M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.21B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.